| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/22/2010 | WO2010018378A3 Vaccine comprising amb 1 a peptides for use in the treatment of ragweed allergy |
| 07/22/2010 | WO2010012745A3 Benzimidazoles |
| 07/22/2010 | WO2009158682A3 Compositions and methods for diagnosing and treating pathogenic disorders |
| 07/22/2010 | US20100184951 Truncated BAFF Receptors |
| 07/22/2010 | US20100184856 Novel Compounds and Uses Thereof for Treating Inflammation and Modulating Immune Responses |
| 07/22/2010 | US20100184834 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 07/22/2010 | US20100184826 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184824 RNA Interference Mediated Inhibition of Interleukin and Interleukin Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 07/22/2010 | US20100184798 Methods to Predict Cholesterol Elevations during Immunosuppressant Therapy |
| 07/22/2010 | US20100184791 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/22/2010 | US20100184789 Inhibitors of protein kinases |
| 07/22/2010 | US20100184780 Inhibitors of protein kinases |
| 07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2010 | US20100184770 Compounds |
| 07/22/2010 | US20100184755 Protein kinase c inhibitors and uses thereof |
| 07/22/2010 | US20100184749 Benzothiadiazine compounds and their use |
| 07/22/2010 | US20100184711 Alpha-GLYCOSYL THIOLS AND alpha-S-LINKED GLYCOLIPIDS |
| 07/22/2010 | US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/22/2010 | US20100184704 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent |
| 07/22/2010 | US20100184698 Use of a deslorelin and mastoparan as a therapeutic agent |
| 07/22/2010 | US20100184689 Pharmaceutical Composition Containing Botulinum Neurotoxin |
| 07/22/2010 | US20100184679 Use of a combination of cart peptides as a therapeutic agent |
| 07/22/2010 | US20100184678 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100184677 Use of the human pancreatic polypeptide as a therapeutic agent |
| 07/22/2010 | US20100184676 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100184675 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent |
| 07/22/2010 | US20100184674 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 07/22/2010 | US20100184673 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent |
| 07/22/2010 | US20100184662 Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis |
| 07/22/2010 | US20100184649 Novel antibacterial agents for the treatment of gram positive infections |
| 07/22/2010 | US20100184646 Melanocortin receptor ligands modified with hydantoin |
| 07/22/2010 | US20100183727 Immunonanotherapeutics that Provide IgG Humoral Response Without T-Cell Antigen |
| 07/22/2010 | US20100183721 Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery |
| 07/22/2010 | US20100183685 Tumor and infectious disease therapeutic compositions |
| 07/22/2010 | US20100183684 Oral vaccination |
| 07/22/2010 | US20100183681 treating a food allergy; orally administer 100 mu g/kg or more of transforming growth factor-beta (TGF- beta ); no side effects |
| 07/22/2010 | US20100183678 Conjugates of plasmodium falciparum surface proteins as malaria vaccines |
| 07/22/2010 | US20100183676 Compositions comprising opa protein epitopes |
| 07/22/2010 | US20100183674 immunization; comprised of a fusion protein; bioterrorism; plague |
| 07/22/2010 | US20100183668 Use of coccidian |
| 07/22/2010 | US20100183667 Vaccine Comprising an Oil in Water Emulsion Adjuvant |
| 07/22/2010 | US20100183662 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 07/22/2010 | US20100183659 Allergen formulation |
| 07/22/2010 | US20100183658 Novel Compounds for Enhancing MHC Class II Therapies |
| 07/22/2010 | US20100183657 Fusion proteins of mycobacterium tuberculosis |
| 07/22/2010 | US20100183647 Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 07/22/2010 | US20100183645 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 07/22/2010 | US20100183642 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 07/22/2010 | US20100183636 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 07/22/2010 | US20100183619 Neutralizing Antibodies and Methods of Use Thereof |
| 07/22/2010 | US20100183615 Cross-species-specific bispecific binders |
| 07/22/2010 | US20100183612 Methods of treatment using ctla4 mutant molecules |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/22/2010 | US20100183602 Induction of Tolerogenic Phenotype in Mature Dendritic Cells |
| 07/22/2010 | US20100183587 Therapeutic Compositions for Treatment of Corneal Disorders |
| 07/22/2010 | US20100183575 Compositions and Methods for Producing Adaptive Regulatory T Cells |
| 07/22/2010 | US20100183573 membrane polypeptide for use in designing therapeutic for proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders; cancer, immunological-related, blood-related and skin-related disorders |
| 07/22/2010 | US20100183571 Treatment of multiple sclerosis using placental stem cells |
| 07/22/2010 | US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof |
| 07/22/2010 | US20100183564 Compounds that expand hematopoietic stem cells |
| 07/22/2010 | US20100183562 Sub -population of hematopoietic stem cells that express the crisp-1 protein |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183543 Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant |
| 07/22/2010 | US20100183541 Methods of Treating Autoimmune Diseases |
| 07/22/2010 | US20100183518 Vaccine Against Group A Beta Hemolytic Streptococcus And Respective Process For Obtaining Thereof |
| 07/22/2010 | CA2749627A1 Recombinant monovalent antibodies |
| 07/22/2010 | CA2749585A1 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| 07/22/2010 | CA2749280A1 Methods for improving hepatic and immune function in an animal |
| 07/22/2010 | CA2748394A1 Oxadiazole derivatives as s1p1 receptor agonists |
| 07/21/2010 | EP2208499A1 Nucleic acid capable of regulating the proliferation of cell |
| 07/21/2010 | EP2207791A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 07/21/2010 | EP2207787A2 Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties |
| 07/21/2010 | EP2207560A2 Use of fibronectin fragment (196-203) as a therapeutic agent |
| 07/21/2010 | EP2207543A2 Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for treating autoimmune diseases or inhibiting immune function |
| 07/21/2010 | EP1692276B1 Method of inducing memory b cell development and terminal differentiation |
| 07/21/2010 | EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis |
| 07/21/2010 | EP1181034B1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
| 07/21/2010 | EP1079825B1 Compounds that inhibit the binding of integrins to their receptors |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN1981750B Soluble A-SH CoA-SH Q10 composition and its production method |
| 07/21/2010 | CN101784566A Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 07/21/2010 | CN101784564A b7-dc variants |
| 07/21/2010 | CN101784535A Novel dicarboxylic acid derivatives as S1P1 receptor agonists |
| 07/21/2010 | CN101781364A Interleukin-1 receptor antagonist |
| 07/21/2010 | CN101781227A 2-N-[(1R, 2R)-1, 3-dihydroxy-1-phenylpropyl]-fatty amide compound, preparation and application thereof |
| 07/21/2010 | CN101780271A Medicinal composition of endotoxin and lectin and application thereof |
| 07/21/2010 | CN101780242A Health or medicine composite and preparation method and application thereof |
| 07/21/2010 | CN101780232A Coix seed oil proliposome and preparation method thereof |
| 07/21/2010 | CN101780191A Method for controlling quality of Resina Draconis-drug extract |
| 07/21/2010 | CN101780190A Quality control method for pharmaceutic preparation containing sanguis draconis extract |
| 07/21/2010 | CN101780185A Health wine |
| 07/21/2010 | CN101780174A Internal medicine combined with Chinese and western medicine for curing allergic rhinitis and preparation method thereof |
| 07/21/2010 | CN101780138A Product for enhancing body immunity and capable of resisting fatigue and preparation method thereof |
| 07/21/2010 | CN101780136A Medicine and food dual-purpose traditional Chinese medicine composition with anti-tumor activity and immunoregulation effect and application thereof |
| 07/21/2010 | CN101780125A Medical application of garden balsam seed for preventing rheumatoid arthritis |
| 07/21/2010 | CN101780119A Cordyceps militaris and Agaricus blazei medicated wine and preparation method thereof |
| 07/21/2010 | CN101780107A Hippocampus extract and preparation method thereof |
| 07/21/2010 | CN101780033A Pre-filled recombinant human interferon injection |
| 07/21/2010 | CN101642528B Production process of compound soft ginsengs |